Golden Biotechnology Corporation (TPEX:4132)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
23.00
+3.15 (15.87%)
At close: Dec 5, 2025

Golden Biotechnology Balance Sheet

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
61.02218.85210.89523.49731.57427.93
Upgrade
Cash & Short-Term Investments
61.02218.85210.89523.49731.57427.93
Upgrade
Cash Growth
-31.71%3.77%-59.71%-28.44%70.96%210.53%
Upgrade
Accounts Receivable
4.92.072.513.522.962.18
Upgrade
Other Receivables
0.271.071.162.350.546.66
Upgrade
Receivables
5.173.143.675.873.58.84
Upgrade
Inventory
5658.1875.575145.52217.25
Upgrade
Prepaid Expenses
9.2310.4415.0115.719.814.7
Upgrade
Other Current Assets
23.782819.2969.57167.7649.2
Upgrade
Total Current Assets
155.19318.6324.36689.631,058717.92
Upgrade
Property, Plant & Equipment
334.09343.83340.56361.42371.81407.58
Upgrade
Other Intangible Assets
29.3828.5727.7528.9628.4733.41
Upgrade
Other Long-Term Assets
28.0131.3121.5423.3629.1525.62
Upgrade
Total Assets
546.67722.3714.211,1031,4881,185
Upgrade
Accounts Payable
0.330.351.664.464.138.07
Upgrade
Short-Term Debt
229.69239.47228228230158
Upgrade
Current Portion of Long-Term Debt
16.6843.346.66.611.6118.03
Upgrade
Current Portion of Leases
15.9815.9512.9313.4711.0617.65
Upgrade
Current Income Taxes Payable
--0.210.020.943.52
Upgrade
Current Unearned Revenue
0.274.092.680.68114.50.36
Upgrade
Other Current Liabilities
24.3641.8533.394939.0238.23
Upgrade
Total Current Liabilities
287.3345.05285.46302.23411.26243.86
Upgrade
Long-Term Debt
36.2737.3916.5323.1329.7338.98
Upgrade
Long-Term Leases
29.2131.217.8713.3410.7321.42
Upgrade
Pension & Post-Retirement Benefits
3.392.892.25---
Upgrade
Total Liabilities
356.17416.54312.11338.7451.72304.26
Upgrade
Common Stock
1,6221,6221,4221,4221,4221,322
Upgrade
Additional Paid-In Capital
-64.2--501.7424.91
Upgrade
Retained Earnings
-1,423-1,372-1,012-650.42-880.25-861.32
Upgrade
Comprehensive Income & Other
-8.58-8.36-8.04-7.17-7.86-5.59
Upgrade
Shareholders' Equity
190.5305.76402.1764.671,036880.27
Upgrade
Total Liabilities & Equity
546.67722.3714.211,1031,4881,185
Upgrade
Total Debt
327.82367.36271.93284.54293.14254.08
Upgrade
Net Cash (Debt)
-266.8-148.51-61.04238.95438.43173.85
Upgrade
Net Cash Growth
----45.50%152.19%-
Upgrade
Net Cash Per Share
-1.66-0.99-0.431.683.311.38
Upgrade
Filing Date Shares Outstanding
162.23162.23142.23142.23142.23132.23
Upgrade
Total Common Shares Outstanding
162.23162.23142.23142.23142.23132.23
Upgrade
Working Capital
-132.12-26.4538.9387.4646.89474.06
Upgrade
Book Value Per Share
1.171.882.835.387.286.66
Upgrade
Tangible Book Value
161.12277.19374.35735.711,007846.86
Upgrade
Tangible Book Value Per Share
0.991.712.635.177.086.40
Upgrade
Land
155.72155.72155.72155.72155.72155.72
Upgrade
Buildings
170.54170.04170.04170.04162.36160.68
Upgrade
Machinery
329.8256255.63241.35217.05211.54
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.